Company Overview

We are developing a pipeline of unique small-molecule product candidates, each with several “shots on goal” in both orphan and major cancer markets. Our goal is address shortcomings of approved therapies and improve the lives of cancer patients whose tumors harbor mutations known to be targeted by our product candidates.